The Simplify Private Credit Strategy ETF (PCR) provides investors with institutional-grade private credit exposure through an ETF, yielding 11.48% as of May 31, 2026. Unlike traditional corporate bonds, PCR invests in business development companies and closed-end funds holding floating-rate senior secured loans, which adjust to interest rate changes, reducing sensitivity to Federal Reserve policies. This structure allows PCR to capture higher yields and mitigate duration risk, making it attractive for income-focused investors seeking resilience in a higher-for-longer interest rate environment. PCR uses total return swaps linked to the VettaFi Private Credit Index to achieve its goals, offering liquidity and cost efficiency uncommon in private credit investments.
Bicara Therapeutics is progressing its Phase 3 trial of ficerafusp alfa for head and neck cancer, expecting interim results by mid-2027 that could support accelerated approval. The company holds nearly $500 million in cash and securities, funding ope...
Mercury Systems reported a Q4 EPS of $0.37, slightly below analyst estimates of $0.38, but exceeded revenue expectations with $289.78 million, a 6.1% increase year-over-year. The company showed robust demand with record bookings of $660 million and a...
Klarna shares dropped 22.81% after cutting its earnings outlook and announcing leadership changes, raising investor concerns. Fabrinet's stock fell 19.38% despite strong quarterly results due to a broader sell-off in AI infrastructure stocks. Leverag...
ProPhase Labs' stock soared 506.62% to $27.48 following a 1-for-4 reverse stock split aimed at consolidating shares and boosting price per share. Other notable gainers include Inpixon (+113%), Super League Gaming (+82%) after a major Bitcoin investme...
American Airlines is bringing back seatback entertainment screens and adding premium seats to its narrowbody jets starting in 2028. This move responds to traveler demand, especially from younger passengers, and aims to close the profit gap with compe...
